Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
04/17/1996 | EP0706656A1 Immunoassay for soluble fibrin polymers |
04/17/1996 | EP0706574A1 Methods for peptide synthesis and purification |
04/17/1996 | EP0706568A1 Vertebrate apoptosis gene: compositions and methods |
04/17/1996 | EP0706567A1 Peptide family, designated as xenonins |
04/17/1996 | EP0706563A1 A truncated keratinocyte growth factor (kgf) having increased biological activity |
04/17/1996 | EP0706319A1 Retroviral vectors capable of expressing multimeric proteins from multiple translational initiation sites |
04/17/1996 | EP0651822B1 Diagnostic method |
04/17/1996 | EP0618815B1 Monoclonal antibodies against type i phospholipase a 2?, used as a therapeutic agent to reduce inflammation |
04/17/1996 | EP0568594B1 NOVEL INSULIN ANALOGS suited for transdermal application |
04/17/1996 | EP0539523B1 Beta chain of the human gm-csf receptor and uses thereof |
04/17/1996 | EP0506826B1 Antibody antagonists of human interleukin-4 |
04/17/1996 | EP0483194B1 IgG3 ANTIBODIES WITH SHORTENED HINGE REGION AND A COMPLEMENT ACTIVATION TEST |
04/17/1996 | EP0428596B1 Novel infectious bursal disease virus |
04/17/1996 | EP0424519B1 Antigenes of the envelope transmembrane glycoprotein of a human retrovirus of the hiv-2 type, and antigens presenting with them an immunological relationship |
04/17/1996 | EP0290565B1 Vaccine containing tick antigens |
04/17/1996 | CN1120854A Rapamycin assay |
04/17/1996 | CN1120853A Method and system for enhanced production of commercially important exoproteins in gram-positive bacteria |
04/16/1996 | US5508386 An immunoglobulin molecule containing a tetrapeptide epitope within the third complementarity-determining region in the n-terminus variable domain thereof |
04/16/1996 | US5508291 Treatment of feline vital disease; antitumor agents |
04/16/1996 | US5508264 Synergistic combinations of a cryif chimeric and cryia(c) chimeric bacillus thuringiensis delta-endotoxin; for controlling lepidopteran pests |
04/16/1996 | US5508263 A solid matrix having a protein coatings prepared from culturing two different nucleotide sequences; repairing bone defects |
04/16/1996 | US5508186 Has vp1 minor structural protein to vp2 major structural protein ratio higher than the ratio of naturally occurring full capsid |
04/16/1996 | US5508182 Esterification of hydrophilic polyols by adsorption onto a solid support and employing a substrate-immiscible solvent |
04/16/1996 | US5508177 Lysing, fractionating, contacting with ion exchange resins, eluting, diluting, contacting with dye-ligand resin, eluting from dye-ligand resin |
04/16/1996 | US5508167 Detecting presence or absence of an apolipoprotein e type 4 isoform(apoe4) in subject by immunoassay |
04/11/1996 | WO1996010641A1 An attenuated vaccination and gene-transfer virus, a method to make the virus and a pharmaceutical composition comprising the virus |
04/11/1996 | WO1996010635A2 Genes encoding signal recognition particle of aspergillus niger |
04/11/1996 | WO1996010629A1 The irs family of genes |
04/11/1996 | WO1996010584A1 Process for extracting high-purity von willebrand factor |
04/11/1996 | WO1996010580A2 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
04/11/1996 | WO1996010419A2 Composition comprising a recombinant virus expressing an antigen and a recombinant virus expressing an immunostimulatory molecule |
04/11/1996 | WO1996010414A1 Trophinin and trophinin-assisting proteins |
04/11/1996 | WO1996010411A1 Immunotherapeutic stress protein-peptide complexes against cancer |
04/11/1996 | WO1996006171A3 New polypetides having a toxic activity against insects of the dipterae family |
04/11/1996 | CA2201748A1 Genes encoding signal recognition particle of aspergillus niger |
04/11/1996 | CA2201498A1 Immunotherapeutic stress protein-peptide complexes against cancer |
04/11/1996 | CA2201474A1 The irs family of genes |
04/11/1996 | CA2201119A1 Trophinin and trophinin-assisting proteins |
04/10/1996 | EP0705903A1 In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene |
04/10/1996 | EP0705901A2 Method of separating recombinant pro-factor IX from recombinant factor IX |
04/10/1996 | EP0705844A1 Gene encoding cationic amino acid transporter protein |
04/10/1996 | EP0705436A1 Method for the diagnosis and analysis of breast carcinoma |
04/10/1996 | EP0705435A1 A novel family of pollen proteinases, methods of use thereof and compositions derived therefrom |
04/10/1996 | EP0705346A1 Monoclonal antibodies against the alpha pdgf receptor and uses thereof |
04/10/1996 | EP0705344A1 Adenovirus vectors for gene therapy |
04/10/1996 | EP0705341A1 Hybrid receptor molecules |
04/10/1996 | EP0705340A1 Toxin gene from xenorhabdus nematophilus |
04/10/1996 | EP0705339A1 Human cell adhesion protein aamp-1 and uses thereof |
04/10/1996 | EP0705338A1 Cloning and recombinant production of crf (corticotropin releasing factor) receptor(s) |
04/10/1996 | EP0705337A1 Clostridium bifermentans dna fragment bearing genes coding for proteins linked to an insecticidal activity |
04/10/1996 | EP0705278A1 Apoptose inhibitor |
04/10/1996 | EP0705277A1 Prostaglandin receptor ep3 and dna encoding it |
04/10/1996 | EP0705276A1 Prostaglandin receptor fp and dna encoding it |
04/10/1996 | EP0537148B1 Purification of human interleukin-4 secreted from an escherichia coli mutant |
04/10/1996 | EP0494135B1 Human "neu" related protein p100 and use of the same for detecting preneoplastic or neoplastic cells in a human |
04/10/1996 | EP0387286B1 Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes |
04/10/1996 | CN1120352A Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same |
04/09/1996 | US5506344 Antibodies specific for BCL-2 gene product |
04/09/1996 | US5506343 Antibodies specific for the DF3 carcinoma associated antigen |
04/09/1996 | US5506342 Chemical reduction, crosslinking, chelating, cleaving and stabilizing |
04/09/1996 | US5506205 Treatment of diabetes |
04/09/1996 | US5506202 Insulin derivatives, a process for the preparation thereof, the use thereof, and a pharmaceutical formulation containing them |
04/09/1996 | US5506135 Fab fragment, having specificities against fibrin and thrombolytic substances |
04/09/1996 | US5506134 Hypridoma and monoclonal antibody which inhibits blood coagulation tissue factor/factor VIIa complex |
04/09/1996 | US5506133 Polypeptide |
04/09/1996 | US5506132 Monoclonal antibodies or binding fragments thereof |
04/09/1996 | US5506121 Fusion peptides with binding activity for streptavidin |
04/09/1996 | US5506120 Method of producing peptides or proteins as fusion proteins |
04/09/1996 | US5506119 DNA encoding variant CD44 surface proteins associated with metastatic tumors |
04/09/1996 | US5506118 Method of using eukaryotic expression vectors comprising a poly GT element in the presence of trans-acting gene products |
04/09/1996 | US5506107 Selecting ligand agonists and antagonists |
04/09/1996 | US5506101 Detecting alteration of wild-type mitochondrial ribosomal rna associated with said deafness; complication of using aminoglycoside antibiotics; screening patients |
04/07/1996 | CA2159958A1 New toxoplasma gondii antigens |
04/05/1996 | CA2159700A1 Method for the separation of recombinant pro-factor ix from recombinant factor ix |
04/04/1996 | WO1996010182A1 Cell tests and diagnostic index for alzheimer's disease |
04/04/1996 | WO1996010089A1 Modification of peptide and protein |
04/04/1996 | WO1996010083A1 Novel pesticidal proteins and strains |
04/04/1996 | WO1996010078A1 A monoclonal antibody to human ventricular myosin light chains |
04/04/1996 | WO1996010077A1 Monoclonal antibody to human cardiac myoglobin |
04/04/1996 | WO1996009835A1 Novel mitogen activated protein kinase, frk |
04/04/1996 | WO1996000288A3 Class bi and ci scavenger receptors |
04/04/1996 | CA2201152A1 A monoclonal antibody to human ventricular myosin light chains |
04/04/1996 | CA2200963A1 Cell tests and diagnostic index for alzheimer's disease |
04/04/1996 | CA2197657A1 Novel mitogen activated protein kinase, frk |
04/03/1996 | EP0704533A1 An attenuated vaccination virus, a method to make the virus and a pharmaceutical compositions comprising the virus |
04/03/1996 | EP0704530A2 A kanamycin resistance gene derived from microorganisms of the genus rhodococcus |
04/03/1996 | EP0704527A2 DNA sequences encoding biosynthetic insulin precursors and process for prepation of insulin |
04/03/1996 | EP0704458A2 Anti-human type IV collagen antibodies and use thereof |
04/03/1996 | EP0704457A1 Allergenic proteins of natural rubber latex, their production and use in assays |
04/03/1996 | EP0704221A2 A conjugate useful in gene transfer and a method of producing the same |
04/03/1996 | EP0704218A2 Bone reinforcing agent and foods and drinks product containing the same |
04/03/1996 | EP0703989A1 COMPOSITIONS AND DIAGNOSTIC METHODS USING MONOCLONAL ANTIBODIES AGAINST CD44v6 |
04/03/1996 | EP0703986A1 Yeast promotor and use thereof |
04/03/1996 | EP0703985A1 Recombinant stratum corneum chymotryptic enzyme (scce) |
04/03/1996 | EP0703981A1 Immunogenic compositions against helicobacter infection, polypeptides for use in the compositions and nucleic acid sequences encoding said polypeptides |
04/03/1996 | EP0703980A1 Intracellular binding proteins and use thereof |
04/03/1996 | EP0703926A1 Recombinant disulfide-stabilized polypeptide fragments having binding specificity |
04/03/1996 | EP0703925A1 Production of antibody fragments |
04/03/1996 | EP0703920A1 Myeloid cell leukemia associated gene mcl-1 |
04/03/1996 | EP0703785A1 Methods for treating muscle diseases and disorders |